Alfirevic, Ana

Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools

Gonzalez-Galarza, F. F., McCabe, A., Santos, E. J. M. D., Jones, J., Takeshita, L., Ortega-Rivera, N. D., Cid-Pavon, G. M. D., Ramsbottom, K., Ghattaoraya, G., Alfirevic, A., et al. (2019) · Nucleic Acids Research

Genetic Associations and EpidemiologyForensic and Genetic Research

Cited by 731

Phenotype standardization for statin-induced myotoxicity

Alfirevic, A., Neely, D., Armitage, J., Chinoy, H., Cooper, R. G., Laaksonen, R., Carr, D. F., Bloch, K. M., Fahy, J., Hanson, A., et al. (2014) · Clinical Pharmacology & Therapeutics

Lipoproteins and Cardiovascular HealthMuscle and Compartmental Disorders

Cited by 220

GATM gene variants and statin myopathy risk

Carr, D. F., Alfirevic, A., Johnson, R., Chinoy, H., van Staa, T., & Pirmohamed, M. (2014) · Nature

Pharmacogenetics and Drug MetabolismLipoproteins and Cardiovascular Health

Cited by 35

Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker–Induced Angioedema

Maroteau, C., Siddiqui, M. K., Veluchamy, A., Carr, F., White, M., Cassidy, A. J., Baranova, E. V., Rasmussen, E. R., Eriksson, N., Bloch, K. M., et al. (2020) · Clinical Pharmacology & Therapeutics

Coagulation, Bradykinin, Polyphosphates, and AngioedemaRenin-Angiotensin System Studies

Cited by 21